A robust cascade-catalytic nanoplatform that integrates redox modulation and immune activation for advanced ferroptosis-enhanced cancer immunotherapy is presented, demonstrating effective tumor accumulation and potent antitumor efficacy.
Abstract
Ferroptosis, an iron-dependent form of programmed cell death, holds significant promise for cancer therapy due to its unique redox-driven mechanism and immunogenic potential. However, its therapeutic efficacy is often compromised by inadequate catalytic kinetics and an unfavorable tumor microenvironment. Here, we develop a multifunctional nanocatalyst (BCuP@G) based on albumin-stabilized polypyrrole doped with multivalent Cu ions and conjugated with glucose oxidase (GOx) to enable enzyme-enhanced cascade catalysis for ferroptosis-immunotherapy. The embedded Cu+/Cu2+ redox centers catalyze glutathione depletion and ·OH generation, while GOx continuously supplies H2O2 through glucose oxidation. Upon NIR-II laser irradiation, the photothermal effect further accelerates both enzymatic and catalytic kinetics, triggering excessive redox imbalance, lipid peroxidation, and synergistic ferroptosis-apoptosis. Moreover, BCuP@G demonstrates effective tumor accumulation and potent antitumor efficacy, particularly in combination with anti-PD-1 therapy, which promotes tumor-associated macrophage repolarization and T cell infiltration. This study presents a robust cascade-catalytic nanoplatform that integrates redox modulation and immune activation for advanced ferroptosis-enhanced cancer immunotherapy.
In vitro and in vivo experiments demonstrate that the self-reinforcing cycle between autophagy and ferroptosis significantly enhances tumor suppression and suggests that targeting iron-autophagy crosstalk with nanomaterials represents a promising strategy for cancer treatment.
Chen-Shuo Wang, Zhen-Zhen Ma, Meng-Yu Liu et al.· European journal of pharmace...· 0 citations
A coordination-driven nanoassembly of ferric-indocyanine green complex in albumin nanocages is reported as an activatable antitumor nanoenzyme for tumor-selective chemodynamic immunotherapy against aggressive cancers.
Ting Li, Xue-Hua Lin, Zhen-Duo Zhao et al.· Journal of Controlled Releas...· 0 citations
In vitro and in vivo evaluations confirm that R-A/G@Z effectively suppresses aggressive breast tumors while maintaining a good safety profile, offering a promising strategy for intelligent metabolic-chemodynamic cancer nanomedicine.
Nian-Ting Xiao, Xiao He, Da-Xiu Li et al.· Journal of Colloid and Inter...· 0 citations
This work presents a mitochondria-targeted, ROS-activatable supramolecular delivery nanoplatform for self-amplifying redox imbalance and reversing cisplatin resistance for enhanced cisplatin-based cancer therapy.
Ying Liu, Zong-Tao Zhou, Wei Ma et al.· International journal of pha...· 0 citations
A structurally reinforced ternary redox-cycling nanoreactor that integrates Zr4⁺-stabilized zeolitic imidazolate framework-8 with redox-active Cu/Mn centers and ultrasmall Au nanodots achieves sustained ROS amplification, iron-homeostasis remodeling, and enhanced tumor-selective ferroptosis, offering a promising therap...
Wan-mei Zhou, Zixin Wang, Chengdong Nie et al.· International journal of pha...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.